Clinical Study of XNW5004 Combined With CHOP/CHOEP in the Treatment of Untreated Peripheral T-Cell Lymphoma

Clinical trial NCT07730515 · RECRUITING

Trial details

NCT number: NCT07730515
Sponsor: Evopoint Biosciences Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-hodgkin Lymphoma Peripheral T-cell Lymphoma

Start date: 2025-08-15
Primary completion: 2028-09-30
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.